Gideon (Gidi) Gross is Scientific Co-founder of GentiBio and member of its scientific advisory board. Gidi is Head of the Immunology Laboratory at MIGAL – Galilee Research Institute in Kiryat Shmona, Israel, and is a senior faculty member at the nearby Tel-Hai College. His research focuses on the development of new gene-based approaches for immunotherapy of multiple diseases. Gidi completed his undergraduate studies at the Open University and obtained his M.Sc. and Ph.D. degrees from the Weizmann Institute of Science in Rehovot, Israel. During his Ph.D. research with Prof. Z. Eshhar, Dr. Gross developed chimeric antigen receptors, laying the ground for CAR-T cell therapy. He conducted his postdoctoral research at the National Cancer Institute in Bethesda, MD, and then at the Laboratory of Molecular Biology of the Medical Research Council in Cambridge, UK.
Gidi Gross, PhD
Professor & PI, MIGAL and Scientific Co-Founder